Morphologic and immunophenotypic features of therapy-related acute myeloid leukemia/myelodysplasia (t-AML/MDS) with balanced 21q22 translocations

被引：0
|
作者：
Arber, DA
Slovak, ML
Popplewell, L
Bedell, V
Rowley, JD
机构：
[1] City Hope Natl Med Ctr, Duarte, CA 91010 USA
[2] Univ Chicago, Chicago, IL 60637 USA
来源：
LABORATORY INVESTIGATION | 2001年 / 81卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
909
引用
收藏
页码：155A / 155A
页数：1
相关论文
共 50 条
  • [31] Amplification or duplication of chromosome band 21q22 with multiple copies of the AML1 gene and mutation of the TP53 gene in therapy-related MDS and AML
    Andersen, MK
    Christiansen, DH
    Pedersen-Bjergaard, J
    LEUKEMIA, 2005, 19 (02) : 197 - 200
  • [32] Identification and characterization of single nucleotide polymorphisms (SNPs) associated with genetic predisposition to develop therapy-related acute myeloid leukemia (t-AML).
    Martinez-Climent, JA
    Guillem, VM
    Tormo, M
    Lluch, A
    Benet, I
    Gonzalez, M
    Nomdedeu, J
    Garcia-Conde, J
    BLOOD, 2004, 104 (11) : 820A - 820A
  • [33] Longitudinal Trends in Peripheral Blood Parameters Predict Development of Therapy-Related Myelodysplasia/Acute Myeloid Leukemia (t-MDS/AML) after Autologous Transplantation for Lymphoma
    Francisco, Liton
    Sun, Can-Lan
    Laddaran, Lester
    Sabado, Melanie
    Bosworth, Alysia
    Chang, Karen L.
    Popplewell, Leslie
    Nademanee, Auayporn P.
    Slovak, Marilyn L.
    Forman, Stephen J.
    Bhatia, Ravi
    Bhatia, Smita
    BLOOD, 2008, 112 (11) : 743 - 743
  • [34] Acute myeloid leukemia (AML) with t(8;21)(q22;q22) relapsing as AML with t(3;21)(q26;q22)
    Bacher, Ulrike
    Schnittger, Susanne
    Kern, Wolfgang
    Trenn, Guido
    Weisser, Martin
    Haferlach, Torsten
    Schoch, Claudia
    CANCER GENETICS AND CYTOGENETICS, 2006, 168 (02) : 172 - 174
  • [35] Risk factors for development of therapy-related leukemia (t-MDS/t-AML) following autologous transplantation (ABMT) for lymphoma.
    Krishnan, A
    Bhatia, S
    Bhatia, R
    Slovak, ML
    Arber, D
    Niland, J
    Fung, H
    Kashyap, A
    Molina, A
    Nademanee, A
    O'Donnell, M
    Parker, P
    Sniecinski, I
    Snyder, D
    Spielberger, R
    Stein, A
    Forman, SJ
    BLOOD, 1998, 92 (10) : 493A - 493A
  • [36] Acute myeloid leukemia with the 8q22;21q22 translocation: secondary mutational events and alternative t(8;21) transcripts
    Peterson, Luke F.
    Boyapati, Anita
    Ahn, Eun-Young
    Biggs, Joseph R.
    Okumura, Akiko Joo
    Lo, Miao-Chia
    Yan, Ming
    Zhang, Dong-Er
    BLOOD, 2007, 110 (03) : 799 - 805
  • [37] BALANCED TRANSLOCATIONS INVOLVING CHROMOSOME BANDS 11Q23 AND 21Q22 ARE HIGHLY CHARACTERISTIC OF MYELODYSPLASIA AND LEUKEMIA FOLLOWING THERAPY WITH CYTOSTATIC AGENTS TARGETING AT DNA-TOPOISOMERASE-II
    PEDERSENBJERGAARD, J
    PHILIP, P
    BLOOD, 1991, 78 (04) : 1147 - 1148
  • [38] Allogeneic stem cell transplantation for therapy-related Myelodysplastic Syndrome (T-MDS) and acute myeloid leukemia (T-AML).: A report from the MDS Subcommittee of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)
    Kroeger, N.
    ANNALS OF HEMATOLOGY, 2008, 87 : S3 - S3
  • [39] Therapy-related acute myeloid leukemia with inv(16)(p13.1q22)
    Chiriac, Radu
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2024, 120 (06) : 654 - 655
  • [40] T(3-21)(Q26-Q22) - A RECURRING CHROMOSOMAL ABNORMALITY IN THERAPY-RELATED MYELODYSPLASTIC SYNDROME AND ACUTE MYELOID-LEUKEMIA
    RUBIN, CM
    LARSON, RA
    ANASTASI, J
    WINTER, JN
    THANGAVELU, M
    VARDIMAN, JW
    ROWLEY, JD
    LEBEAU, MM
    BLOOD, 1990, 76 (12) : 2594 - 2598
12345